Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
The future of health data interoperability using FHIR. ONC’s Micky Tripathi provided his perspective at a recent Cambia Grove forum.
On August 24, Keya Medical’s flagship product, DeepVessel FFR, was successfully implemented in Beijing Anzhen Hospital.
Artificial intelligence and other advanced informatics could be applied to coronary CTA images to unlock valuable information on atherosclerotic plaque characteristics that could be used to personalize care decisions. Learn more.
Learn more about the encouraging recent developments in the use of targeted fee-for-service models as a transition strategy to ensure that patients have access to proven advanced diagnostics and treatments.
Examine the current challenges for coronary CTA reimbursement, the potential effects it will have on patient care, and what medical imagers can do to help improve reimbursement moving forward.
Keya Medical showcased its deep learning-based diagnostic and treatment solutions at the World Artificial Intelligence Conference 2021 (WAIC 2021) held in Shanghai.
Artificial intelligence has made its way into nearly every aspect of cardiovascular imaging. Learn more about six must-read articles on cardiovascular imaging AI that provide insight into the many ways AI can improve care delivery.
Recent research demonstrates that deep learning could facilitate opportunistic screening and allow for earlier prevention and management of patients with cardiovascular disease. Learn more about the present opportunities.
The concept of a Smart Hospital is evolving in 2021. Read how new hospital construction can anticipate climate change, decentralization of care delivery, and advances in medical science.
Deep learning-based CT-FFR has demonstrated potential in improving the diagnosis of patients with coronary artery disease. Learn more about how deep learning-based CT-FFR can help improve patient outcomes in this introductory guide.
The expression “time is brain” has been used to demonstrate the importance of urgency in treating stroke patients. Learn more about how AI can help transform the diagnosis and treatment of stroke patients to improve outcomes.
Keya Medical was recognized on the Top 100 Future Medical Companies List at the Fifth Future Healthcare VB100 Conference.
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.